New Jersey Court Throws Out $223.8M Verdict Against Johnson & Johnson In Talc Powder Cancer Lawsuit
Portfolio Pulse from Benzinga Newsdesk
A New Jersey court has dismissed a $223.8 million verdict against Johnson & Johnson in a lawsuit related to its talc powder causing cancer.
October 03, 2023 | 1:45 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Johnson & Johnson's legal burden has been reduced as a New Jersey court dismissed a $223.8 million verdict against the company in a talc powder cancer lawsuit.
The dismissal of the $223.8 million verdict against Johnson & Johnson reduces the company's legal liabilities, which could have a positive impact on its stock price in the short term. The news may also improve investor sentiment towards the company.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 100